FIXX - Homology Medicines - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

FIXX is currently covered by 7 analysts with an average price target of $9.03. This is a potential upside of $8.1 (870.97%) from yesterday's end of day stock price of $0.93.

Homology Medicines's activity chart (see below) currently has 20 price targets and 33 ratings on display. The stock rating distribution of FIXX is 53.33% BUY and 46.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.25% with an average time for these price targets to be met of 6.5 days.

Highest price target for FIXX is $20, Lowest price target is $1.5, average price target is $9.03.

Most recent stock forecast was given by MADHU KUMAR from on 28-Jul-2023. First documented stock forecast 24-Apr-2018.

Currently out of the existing stock ratings of FIXX, 8 are a BUY (53.33%), 7 are a HOLD (46.67%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1.5

$0.64 (74.42%)

10

8 months 22 days ago

1/8 (12.5%)

$0.17 (12.78%)

5

Buy

20

$18.97 (1841.75%)

11 months 4 days ago

0/1 (0%)

$18.98 (1860.78%)

Hold

2

$1.14 (132.56%)

3.21

11 months 7 days ago

2/4 (50%)

$1.02 (104.08%)

60

Buy

7

1 years 13 days ago

0/3 (0%)

$4.46 (175.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FIXX (Homology Medicines) average time for price targets to be met?

On average it took 6.5 days on average for the stock forecasts to be realized with a an average price target met ratio 6.25

Which analyst has the current highest performing score on FIXX (Homology Medicines) with a proven track record?

RICHARD LAW

Which analyst has the most public recommendations on FIXX (Homology Medicines)?

Richard Law works at GOLDMAN SACHS and has 2 price targets and 2 ratings on FIXX

Which analyst is the currently most bullish on FIXX (Homology Medicines)?

Patrick Trucchio with highest potential upside - $18.97

Which analyst is the currently most reserved on FIXX (Homology Medicines)?

Michelle Gilson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?